The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional randomized controlled trials (RCTs), computational modeling and simulation (CM&S ...

Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...

The durability of communication with the use of brain–computer interfaces in persons with progressive neurodegenerative disease has not been extensively examined. We report on 7 years of independent ...

The device could help address multiple neurological conditions if it proves successful. One early use could be delivering ...